Literature DB >> 16310413

Chemokines in host-parasite interactions in leishmaniasis.

Maria Jania Teixeira1, Clarissa Romero Teixeira, Bruno Bezerril Andrade, Manoel Barral-Netto, Aldina Barral.   

Abstract

Crucial to the defense against leishmaniasis is the ability of the host to mount a cell-mediated immune response capable of controlling and/or eliminating the parasite. Cell recruitment to the site of infection is essential to the development of the host cellular immune response. The process is controlled by chemokines, which are chemotactic cytokines produced by leukocytes and tissue cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16310413     DOI: 10.1016/j.pt.2005.11.010

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  41 in total

1.  Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to Leishmania braziliensis.

Authors:  Nicolas Barros; Nestor Vasquez; Fernando Woll; Cesar Sanchez; Braulio Valencia; Alejandro Llanos-Cuentas; A Clinton White; Martin Montes
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

2.  Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression.

Authors:  Adriana Navas; Deninson Alejandro Vargas; Marina Freudzon; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

3.  Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.

Authors:  M Van den Kerkhof; L Van Bockstal; J F Gielis; P Delputte; P Cos; L Maes; Guy Caljon; Sarah Hendrickx
Journal:  Parasitol Res       Date:  2018-08-23       Impact factor: 2.289

4.  Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response.

Authors:  Paulo R Machado; Maria Elisa A Rosa; Diego Costa; Moema Mignac; João S Silva; Albert Schriefer; Mauro M Teixeira; Olivia Bacellar; Edgar M Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-02       Impact factor: 2.184

5.  Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.

Authors:  Henry W Murray; Andrew D Luster; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 6.  Role of chemokines in regulation of immunity against leishmaniasis.

Authors:  Steve Oghumu; Claudio M Lezama-Dávila; Angelica P Isaac-Márquez; Abhay R Satoskar
Journal:  Exp Parasitol       Date:  2010-03-03       Impact factor: 2.011

7.  L-arginine and cationic amino acid transporter 2B regulate growth and survival of Leishmania amazonensis amastigotes in macrophages.

Authors:  Nanchaya Wanasen; Carol L MacLeod; Lesley G Ellies; Lynn Soong
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

8.  Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.

Authors:  Rúbia S Costa; Lucas P Carvalho; Taís M Campos; Andréa S Magalhães; Sara T Passos; Albert Schriefer; Juliana A Silva; Ednaldo Lago; Camilla S Paixão; Paulo Machado; Phillip Scott; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

9.  Combination of Mycobacterium indicus pranii and Heat-Induced Promastigotes Cures Drug-Resistant Leishmania Infection: Critical Role of Interleukin-6-Producing Classical Dendritic Cells.

Authors:  Somaditya Dey; Debarati Mukherjee; Sirin Salma Sultana; Suvadip Mallick; Aritri Dutta; Joydip Ghosh; Aabid Hussain; Biswajyoti Sarkar; Supratim Mandal; Pradyumna Patra; Bhaskar Saha; Chiranjib Pal
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

10.  CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study.

Authors:  Léa Castellucci; Sarra E Jamieson; E Nancy Miller; Eliane Menezes; Joyce Oliveira; Andrea Magalhães; Luiz Henrique Guimarães; Marcus Lessa; Amélia Ribeiro de Jesus; Edgar M Carvalho; Jenefer M Blackwell
Journal:  BMC Med Genet       Date:  2010-01-20       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.